No Detail Found!

Effect of Propranolol in Hepatic Blood Flow: A Way to Encounter Phenytoin Induced Hepatotoxicity in Albino Rabbits

Author(s)
Hina Abrar Dow College of Pharmacy, Dow University of Health Sciences, Ojha Campus, Gulzar E Hijri, Scheme-33, Karachi, Pakistan
Hina Yasin Dow College of Pharmacy, Dow University of Health Sciences, Ojha Campus, Gulzar E Hijri, Scheme-33, Karachi, Pakistan
Hira Naeem Baqai Institute of Pharmaceutical Sciences, Baqai Medical University, Super Highway, Gadap Road, Karachi, Pakistan
Rabia Bushra Dow College of Pharmacy, Dow University of Health Sciences, Ojha Campus, Gulzar E Hijri, Scheme-33, Karachi, Pakistan
Shaukat Mahmood Baqai Institute of Pharmaceutical Sciences, Baqai Medical University, Super Highway, Gadap Road, Karachi, Pakistan
Kaneez Fatima Institute of Pharmaceutical Sciences, Jinnah Sindh Medical University, Rafiqui H.J Shaheed Road, Karachi, Pakistan
Abstract
Phenytoin has proved to be the most effective anti-seizure drug to treat the partial and tonic clonic seizure. However; hepatotoxicity associated with the Phenytoin (PHY) is of great concern in clinical settings. Contrarywise, Propranolol (PRL) is reported to possess the significant hepatoprotective effects owing to the reduced blood flow. Therefore, the present study was aimed to evaluate the hepatotoxicity of PHY alone and in combination with PRL in healthy male rabbits. Post treatment level of various liver enzymes including alanine transaminase (ALT), alkaline phosphatase (ALP), gamma-glutamyltransferase (?-GT) and bilirubin (BRB) were measured and compared with the normal values. Additionally, histological examination was done through micrometry and scanning electron microscopy (SEM) to estimate the intensity of hepatotoxicity induced by PHY and PHY with PRL. Animals received PHY alone treatment showed a significant elevation of liver enzymes than control and combination. Conversely, the lower level of serum ALT, ALP, ?GT and BRB were found when administered PRL with PHY (p<0.005). Prominent change in hepatic cells structure and diameter of nucleus were observed (p<0.05). Severe hepatic damage reflected by necrosis, hemorrhage and dilation of sinusoids, inflammation with dilation and congestion of portal vein were obvious in PHY treated group. Combination treatment of PHY with PRL showed normal liver function and identical tissue pattern as control group exhibited. It is concluded that the PRL actually reduces the blood flow to the liver consequently, supply of noxious substance is blocked. Henceforth, the PRL would provide the beneficial effects when co-administered with the hepato-toxic drugs.
Publication Details
Page(s) 2635-2643
Published Journal: Pakistan Journal of Zoology, Volume: 56, Issue: 6, Year: 2024

Request the full text from PASTIC

Keywords
hepatoprotective, Scanning electron microscopy, Phenytoin, Hepatotoxicity, micrometry, Propranolol
References
Abrar H.,Naqvi S.,Ahmed M.R.,Ali A.B.,Yasin A.B. .2019 .Ameliorating efect of a betablocker, propranolol on carbamazepine-induced hepatotoxicity in rabbits. Pakistan J. Zool., 51 : 341-346.
Albus U. .2012 .Guide for the care and use of laboratory animals (8th edn). Sage Publications Sage UK, : .
Altuntas Y.,Ozturk B.,Erdem L.,Gunes G.,Karul S.,Ucak S.,Sengul A. .2003 .Phenytoininduced toxic cholestatic hepatitis in a patient with skin lesions: Case report. , 0000051269 : 201-204.
Alturkistani H.A.,Tashkandi F.M.,Mohammedsaleh Z.M. .2016 .Histological stains: A literature review and case study. Glob. J. Hlth. Sci., 8 : 72.
Bhadoria P.,Nagar M.,Bahrioke V.,Bhadoria A.S. .2015 .Efect of ethephon on the liver in albino rats: A histomorphometric study. Biomed. J., 38 : 155589-4170.
Björnsson E. .2008 .Hepatotoxicity associated with antiepileptic drugs. Acta Neurol, 01009 : 0404-290.
Bosia J.,Borzi S.,Cocozzella D.,Corallini O.,Mayet M.,Malca M.,Padrone M.,Rivero A.,Cecchi G.,Fraquelli E. .1999 .Acute liver failure by diphenylhydantoin. Acta gastroenterol. Latinoam., 30 : 73-76.
Cadman B.,Featherstone B. .2003 .Adverse efects of drugs on the liver. Churchill Livingstone, : 843-852.
Curry B.,Mican L.,Smith T.L. .2018 .Phenytoininduced chronic liver enzyme elevation and hepatic ifbrosis: A case report. Mental Hlth. Clin., 07 : 184-187.
D'amico M.,Mejías M.,García-Pras E.,Abraldes J.G.,Garcia-Pagan J.C.,Fernández M.,Bosch J. .2012 .Efects of the combined administration of propranolol plus sorafenib on portal hypertension in cirrhotic rats. Am. J. Physiol. Gastrointest. Liver Physiol, 302 : G1191-G1198.
Dib N.,Oberti F.,Calès P. .2006 .Current management of the complications of portal hypertension: Variceal bleeding and ascites. Can. med, 174 : 1433-1443.
Diwan B.A.,Henneman J.R.,Nims R.W.,Rice J.M. .1993 .Tumor promotion by an anticonvulsant agent, phenytoin, in mouse liver: Correlation with CYP2B induction. Carcinogenesis, 14 : 2227-2231.
Ekaidem I.S.,Akpanabiatu M.I.,Uboh F.E.,Eka O.U. .2007 .Efect of folic acid and vitamin B12 administration on phenytoin induced toxicity in rats. Indian J. clin. Biochem, 22 : 36-40.
Feroz Z.,Khan R.A. .2013 .Hepatoprotective efect of herbal drug on CCl 4 induced liver damage. Pak. J. Pharma. Sci., 26 : 99-103.
Fizanne L.,Régenet N.,Wang J.,Oberti F.,Moal F.,Roux J.,Gallois Y.,Michalak S.,Calès P. .2008 .Hemodynamic efects of the early and long-term administration of propranolol in rats with intrahepatic portal hypertension. Hepatol. Int., 2 : 457-464.
García-Estrada J.,Navarro-Ruíz A.,RománMaldonado S.,Bastidas-Ramírez B.,GonzálezHita M.,Navarro-Ruiz I. .1990 .Oral administration of diphenylhydantoin sodium (DFH-Na or phenytoin) predictably afects the liver and kidney of Sprague Dawley rats. Arch. Investig. Med, 21 : 339-347.
Garzón D.L.M.P.,García-Estrada J.,Navarro-Ruíz A.,Román-Maldonado S.,Bastidas-Ramírez B.,González-Hita M.,Navarro-Ruiz I. .1989 .Oral administration of diphenylhydantoin sodium (DFH-Na or phenytoin) predictably afects the liver and kidney of Sprague Dawley rats. Arch. Invest. Med, 21 : 339-347.
Gazzard B.,Hughes R.,Portmann B.,Dordoni B.,Williams R. .1974 .Protection of rats against the hepatotoxic efect of paracetamol. Br. J. exp. Pathol, 55 : 601.
Huang Q.,Jin X.,Gaillard E.T.,Knight B.L.,Pack F.D.,Stoltz J.H.,Jayadev S.,Blanchard S. .2003 .Gene expression profiling reveals multiple toxicity endpoints induced by hepatotoxicants. Mutat. Res. Fundam. Mol. Mech, 12 : 147-167.
Huang Y-Y.,Chung T-W.,Tzeng T-W. .1997 .Drug release from PLA/PEG microparticulates. Int. J. Pharma., 5173(97) : 00154-3.
Hussein R.R.,Soliman R.H.,Ali A.M.A.,Tawfeik M.H.,Abdelrahim M.E. .2013 .Efect of antiepileptic drugs on liver enzymes. Beni-Suef Univ. J. Basic appl. Sci., 09 : 14-19.
Imosemi I.,Osinubi A.,Saalu L.,Olagunju J.A. .2010 .Phenytoin-induced toxicity in the postnatal cerebellar development in rat: Efect of calotropis procera on selective biochemical and haematological variables. Int. J. biol. chem. Sci., 4 : 64974-2396.
Kamp H.,Fabian E.,Groeters S.,Herold M.,Krennrich G.,Looser R.,Mattes W.,Mellert W.,Prokoudine A.,Ruiz-Noppinger P. .2012 .Application of in vivo metabolomics to preclinical/ toxicological studies: Case study on phenytoininduced systemic toxicity. Bioanalysis, 4 : 2291-2301.
Kaplowitz N. .2004 .Drug-induced liver injury. Clin. Infect. Dis., 38 : S44-S48.
Koshy A. .2006 .Medical treatment of portal biliopathy. J. clin. Gastroenterol, 40 : 00004836-454.
Mahendra A.,Hendra P. .2011 .Efek hepatoprotektif infusa daun Macaranga tanarius L. pada tikus jantan terinduksi parasetamol. J. Farmasi Sains dan Komunitas, 8 : 91-99.
Misra H.,Singh S.,Shukla B.,Rai Y.K. .2013 .A study of efect of phenytoin on liver enzymes in epileptic patients in western Uttar Pradesh. -1032.1.2.026, 1 : 11.
Murtey M.D.,Ramasamy P. .2016 .Modern electron microscopy in physical and life sciences. Intech Open, : .
Owoeye O.,Adedara I.A.,Adeyemo O.A.,Bakare O.S.,Egun C.,Farombi E.O. .2014 .Modulatory role of kolaviron in phenytoin-induced hepatic and testicular dysfunctions in Wistar rats. J. Diet. Suppl., 12 : 105-117.
Parasuraman S.,Raveendran R.,Kesavan R. .2010 .Blood sample collection in small laboratory animals. J. Pharmacol. Pharmacother., 1 : 72350-500X.
Patocka J.,Wu Q.,Nepovimova E.,Kuca K. .2020 .Phenytoin-An anti-seizure drug: Overview of its chemistry, pharmacology and toxicology. Fd. Chem, : 111393.
Pizcueta M.P.,De Lacy A.M.,Kravetz D.,Bosch J.,Rodés J. .1989 .Propranolol decreases portal pressure without changing portocollateral resistance in cirrhotic rats. Hepatology, 10 : 953-957.
Poddar U.,Shava U.,Yachha S.K.,Agarwal J.,Kumar S.,Baijal S.S.,Srivastava A. .2015 .β-Blocker therapy ameliorates hypersplenism due to portal hypertension in children. Hepatol. Int., 9 : 447-453.
Rasheed S.,Amanullah A.,Rehman M.H.U.,Javed M. .2012 .Architectural changes of liver in response to alcohol. Gomal J. med. Sci., 9 : 204-207.
Santos N.,Medina W.,Martins N.,Rodrigues M.C.,Curti C.,Santos A. .2008 .Involvement of oxidative stress in the hepatotoxicity induced by aromatic antiepileptic drugs. Toxicol, 08 : 1820-1824.
Saraswathy G.,Maheswari E.,Santhrani T. .2010 .Efect of vitamin C supplementation on phenytoin induced hepatotoxicity. Glob. J. Pharmacol., 4 : 127-135.
Saraswathy G.,Maheswari E.,Santhrani T. .2015 .Protective efect of alpha lipoic acid against phenytoin induced behavioral abnormalities in rats. J. Mol. Biomark, : 1000241-9929.
Sasaki E.,Matsuo K.,Iida A.,Tsuneyama K.,Fukami T.,Nakajima M.,Yokoi T. .2013 .A novel mouse model for phenytoin-induced liver injury: Involvement of immune-related factors and P450- mediated metabolism. Toxicol. Sci., 136 : 250-263.
Schmidt D.,Schachter S.C. .2014 .Drug treatment of epilepsy in adults. Br. med. , 348 : .
Sen S.,Ratnaraj N.,Davies N.A.,Mookerjee R.P.,Cooper C.E.,Patsalos P.N.,Williams R.,Jalan R. .2003 .Treatment of phenytoin toxicity by the molecular adsorbents recirculating system (MARS). Epilepsia, 31402 : 1157-267.
Sharma V.,Janmeda P. .2013 .Chemopreventive role of Euphorbia neriifolia (Linn) and its isolated lfavonoid against N-nitrosodiethylamine-induced renal histopathological damage in male mice. Toxicol. Int., 20 : 111554-6580.
Singh M.,Shah G.,Singh K. .2000 .Teratogenic efects of dilantin on thoraco-abdominal organs of developing chick embryos. Indian J. exp. Biol, 38 : 1026-1030.
Smythe M.,Umstead G. .1989 .Phenytoin hepatotoxicity: A review of the literature. DICP Annls Pharmacother., 23 : 13-18.
Tursi T. .2010 .Use of ss-blocker therapy to prevent primary bleeding of esophageal varices. J. Am. Acad. Nurse Pract, 00567 : 7599-647.
Vidaurre J.,Gedela S.,Yarosz S. .2017 .Antiepileptic drugs and liver disease. Pediatr. Neurol., 09 : 23-36.
Yoon E.,Babar A.,Choudhary M.,Kutner M.,Pyrsopoulos N. .2015 .Acetaminophen-induced hepatotoxicity: A comprehensive update. J. clin. Transl, 4 : 131.
0

Citations

0

Downloads

105

Views